NDC 17856-0353-2 - Pharbetol Regular strength
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-0353
- Requested NDC
- 17856-0353-2
- Package NDCs from labels
- 17856-0353-2, 17856-0353-1, 17856-0353-4, 17856-0353-3
- Manufacturer
- ATLANTIC BIOLOGICALS CORP.
- Effective date
- 2025-06-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| PHARBEST IBUPROFEN Drug Facts | ATLANTIC BIOLOGICALS CORP. | 2025-06-05 | HUMAN OTC DRUG LABEL |
| Pharbetol Regular strength - ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS | ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS | 2024-04-30 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 17856-0353-1 | 2024-06-26 | C162847 | 48780-1 | 1030e365-250f-111a-e063-dadaa90a10e2 | PHARBEST IBUPROFEN Drug Facts |
| 17856-0353-1 | 2024-01-30 | C162847 | 48780-1 | 1030e365-250f-111a-e063-dadaa90a10e2 | PHARBEST IBUPROFEN Drug Facts |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0353-1 | PharbetolRegular strength | 100 in 1 BOX, UNIT-DOSE | TABLET | 100 | 3 | |
| 17856-0353-2 | PharbetolRegular strength | 1 in 1 POUCH | TABLET | 1 | 3 | |
| 17856-0353-4 | PharbetolRegular strength | 24 in 1 BOTTLE | TABLET | 24 | 3 | |
| 17856-0353-3 | PharbetolRegular strength | 28 in 1 BOTTLE | TABLET | 28 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-0353 | PHARBETOL REGULAR STRENGTH (ACETAMINOPHEN) TABLET [ATLANTIC BIOLOGICALS CORP.] | 2 | Current NDC, Legacy NDC, 3 package rows | 20240627_05a91d24-b498-4ba2-a275-68b871cf62d2.zip |
| 17856-0353 | PHARBETOL REGULAR STRENGTH (ACETAMINOPHEN) TABLET [ATLANTIC BIOLOGICALS CORP.] | 1 | Current NDC, Legacy NDC, 1 package rows | 20240508_bd26081c-e81e-42e8-b3da-2813863a51df.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Night Time Multi-Symptom Cold and Flu Relief | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE | Discount Drug Mart | 8148c2b1-f6ec-4597-8e18-a6597cda5705 | 2025-12-19 | Warnings | 362O9ITL9D |
| ACETAMINOPHEN 500 MG | ACETAMINOPHEN | NUVICARE LLC | 591ee107-e953-4982-b75f-13a0afd7c4ae | 2025-12-19 | Warnings | M013 362O9ITL9D |
| Nuvicare Headache Relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | NUVICARE LLC | 3ede0fb6-c089-4253-9878-2b01c39e9c87 | 2025-12-19 | Warnings | M013 362O9ITL9D |
| Aspirin Low Dose | ASPIRIN | NUVICARE LLC | 3a4aa3c7-b726-4303-8803-74196fa5637a | 2025-12-19 | Warnings | M013 |
| ACETAMINOPHEN 500 MG | ACETAMINOPHEN | NUVICARE LLC | 95edf7bd-b6a7-4be5-9ad7-8748e7c2d06e | 2025-12-19 | Warnings | M013 362O9ITL9D |
| Pain Relief PM | ACETAMINOPHEN, DIPHENHYDRAMINE | NUVICARE LLC | 32a5611b-9bf6-4850-a7ff-fa240da04f45 | 2025-12-19 | Warnings | M013 362O9ITL9D |
| Acetaminophen | ACETAMINOPHEN | BETTER LIVING BRANDS LLC. | ac0e96d0-746e-fb42-e053-2a95a90a1957 | 2025-12-18 | Warnings | M013 362O9ITL9D |
| Acetaminophen | ACETAMINOPHEN | BETTER LIVING BRANDS LLC. | ac0e5dc0-96eb-47b2-e053-2995a90add0e | 2025-12-18 | Warnings | M013 362O9ITL9D |
| Acetaminophen Diphenhydramine HCl | ACETAMINOPHEN DIPHENHYDRAMINE HCL | BETTER LIVING BRANDS LLC. | ac0f8d5c-d200-1156-e053-2a95a90aece6 | 2025-12-18 | Warnings | M013 362O9ITL9D |
| Acetaminophen | ACETAMINOPHEN | Caplin Steriles Limited | b6f83919-8608-4648-9ac6-e13eadac8404 | 2025-12-18 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Pain and Fever Childrens | ACETAMINOPHEN | CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED | e55645ab-66f9-4160-8247-395bc5b02711 | 2025-12-18 | Warnings | M013 362O9ITL9D |
| Hydrocodone Bitartrate and Acetaminophen | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | Aurolife Pharma, LLC | 392a846e-7325-462d-b19b-8afda44c5cb0 | 2025-12-17 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| CareOne Childrens Acetaminophen | ACETAMINOPHEN | American Sales Company | 07bc6632-fabb-427d-81f3-c27c54caa6a0 | 2025-12-17 | Warnings | M013 362O9ITL9D |
| Acetaminophen and Ibuprofen | ACETAMINOPHEN AND IBUPROFEN | WALGREEN COMPANY | 2789fdef-2d8e-6247-e063-6394a90a974b | 2025-12-16 | Warnings | 362O9ITL9D |
| Cold and Flu Nighttime | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE | QUALITY CHOICE (Chain Drug Marketing Association) | ca6d43cf-0d1f-4d3c-be7e-e3ac6a24f4fe | 2025-12-16 | Warnings | 362O9ITL9D |
| Cold and Flu Nighttime | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE | QUALITY CHOICE (Chain Drug Marketing Association) | e70d0784-53bc-4910-aade-3c9ad6e36441 | 2025-12-16 | Warnings | 362O9ITL9D |
| MAXIMUM STRENGTH NON-ASPIRIN 100 | ACETAMINOPHEN | JHK Inc dba American Safety & First Aid | 1d3e9948-883e-4668-9bb8-d699a283b51a | 2025-12-16 | Warnings | M013 362O9ITL9D |
| Pain and Sinus | ACETAMINOPHEN AND PHENYLEPHRINE | JHK Inc dba American Safety & First Aid | 88f86f5a-cc2b-4c75-b7a4-f2021922280b | 2025-12-16 | Warnings | 362O9ITL9D |
| Daytime Cold and Flu Non Drowsy | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE | QUALITY CHOICE (Chain Drug Marketing Association) | df866cf6-0526-4e61-ac9b-245b57dd5df6 | 2025-12-16 | Warnings | 362O9ITL9D |
| Severe Cold and Flu Relief Daytime | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE | Walgreens | c89200b6-4adb-452e-b931-07f631dad641 | 2025-12-16 | Warnings | 362O9ITL9D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.